• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

1

CATEGORIES

  • 12
  • 8
  • 4
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

0
1
1
25

PUBLISHED

0
1
14
25

PRODUCT TYPE

25

Search "InDex Pharmaceuticals AB-Therapeutic Competitors Report" returned 25 results.

Pulmonary Inflammation - Pipeline Review, H1 2014

Pulmonary Inflammation - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Pulmonary Inflammation - Pipeline Review, H1 2014’, provides an overview of the Pulmonary Inflammation’s therapeutic...

May 2014
FROM

Competitor Analysis - Antibody Therapy of Inflammatory and Autoimmune Diseases

The present Competitive Intelligence Report about Antibody Therapy of Inflammatory and Autoimmune Diseases provides a competitor evaluation in the field of antibody therapeutics used or being developed...

December 2010
FROM

Acromegaly - Pipeline Review, H1 2014

Acromegaly - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Acromegaly - Pipeline Review, H1 2014’, provides an overview of the Acromegaly’s therapeutic pipeline. This report provides...

March 2014
FROM

Acromegaly - Pipeline Review, H1 2015

Acromegaly - Pipeline Review, H1 2015 Summary This, ‘Acromegaly - Pipeline Review, H1 2015’, provides an overview of the Acromegaly’s therapeutic pipeline. This report provides comprehensive information...

May 2015
FROM

Neuroendocrine Tumors - Pipeline Review, H2 2014

Neuroendocrine Tumors - Pipeline Review, H2 2014 Summary This, ‘Neuroendocrine Tumors - Pipeline Review, H2 2014’, provides an overview of the Neuroendocrine Tumors’s therapeutic pipeline. This report...

October 2014
FROM

Breast Cancer - Pipeline Review, H2 2014

Breast Cancer - Pipeline Review, H2 2014 Summary This, ‘Breast Cancer - Pipeline Review, H2 2014’, provides an overview of the Breast Cancer’s therapeutic pipeline. This report provides comprehensive...

November 2014
FROM

Prostate Cancer - Pipeline Review, H2 2014

Prostate Cancer - Pipeline Review, H2 2014 Summary This, ‘Prostate Cancer - Pipeline Review, H2 2014’, provides an overview of the Prostate Cancer’s therapeutic pipeline. This report provides comprehensive...

August 2014
FROM

Urinary Tract Infections - Pipeline Review, H1 2015

Urinary Tract Infections - Pipeline Review, H1 2015 Summary This, ‘Urinary Tract Infections - Pipeline Review, H1 2015’, provides an overview of the Urinary Tract Infections’s therapeutic pipeline. This...

January 2015
FROM

Neuroendocrine Tumors - Pipeline Review, H1 2014

Neuroendocrine Tumors - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Neuroendocrine Tumors - Pipeline Review, H1 2014’, provides an overview of the Neuroendocrine Tumors’s therapeutic...

April 2014
FROM

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2014

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Metastatic Hormone Refractory (Castration Resistant,...

February 2014
FROM

Breast Cancer - Pipeline Review, H1 2015

Breast Cancer - Pipeline Review, H1 2015 Summary This, ‘Breast Cancer - Pipeline Review, H1 2015’, provides an overview of the Breast Cancer’s therapeutic pipeline. This report provides comprehensive...

January 2015
FROM

Bone Metastasis - Pipeline Review, H2 2014

Bone Metastasis - Pipeline Review, H2 2014 Summary This, ‘Bone Metastasis - Pipeline Review, H2 2014’, provides an overview of the Bone Metastasis’s therapeutic pipeline. This report provides comprehensive...

September 2014
FROM

Bone Metastasis - Pipeline Review, H1 2014

Bone Metastasis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Bone Metastasis - Pipeline Review, H1 2014’, provides an overview of the Bone Metastasis’s therapeutic pipeline. This...

March 2014
FROM

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2014

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2014 Summary This, ‘Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer...

November 2014
FROM

Multiple Sclerosis - Pipeline Review, H2 2014

Multiple Sclerosis - Pipeline Review, H2 2014 Summary This, ‘Multiple Sclerosis - Pipeline Review, H2 2014’, provides an overview of the Multiple Sclerosis’s therapeutic pipeline. This report provides...

September 2014
FROM

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015 Summary This, ‘Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer...

January 2015
FROM

Ulcerative Colitis - Pipeline Review, H1 2014

Ulcerative Colitis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Ulcerative Colitis - Pipeline Review, H1 2014’, provides an overview of the Ulcerative Colitis’s therapeutic pipeline. This...

February 2014
FROM

Ulcerative Colitis - Pipeline Review, H2 2014

Ulcerative Colitis - Pipeline Review, H2 2014 Summary This, ‘Ulcerative Colitis - Pipeline Review, H2 2014’, provides an overview of the Ulcerative Colitis’s therapeutic pipeline. This report provides...

October 2014
FROM

Acromegaly - Pipeline Review, H2 2014

Acromegaly - Pipeline Review, H2 2014 Summary This, ‘Acromegaly - Pipeline Review, H2 2014’, provides an overview of the Acromegaly’s therapeutic pipeline. This report provides comprehensive information...

August 2014
FROM

Prostate Cancer - Pipeline Review, H1 2014

Prostate Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Prostate Cancer - Pipeline Review, H1 2014’, provides an overview of the Prostate Cancer’s therapeutic pipeline. This...

June 2014
FROM
Loading Indicator

Our Clients

Credit Suisse Group Heinz Company Telenor Group Deutsche Bank AG Solvay S.A. APC by Schneider Electric Lindt & Sprüngli AG